Some stroke patients suffer from early seizures and status epilepticus and are prescribed antiseizure medications. Despite these medicines, many people still suffer from seizure recurrence. In fact, a study published in 2013 found that 7% of people who suffered a stroke went on to develop epilepsy. Advances in acute stroke management have led to improved survival after stroke, and therefore, more people are expected to develop post-stroke epilepsy. Post-stroke seizures are often associated with significantly increased mortality and severe disability in patients. Thus, it is critical to speak to stroke patients to create awareness about the complications of stroke including epilepsy and understand how this condition affects their care and quality of life.
In this webinar, attendees will learn:
1. the epidemiology of post-stroke epilepsy.
2. the complications of post-stroke epilepsy.
3. the international efforts to promote research on this topic.
This will be the first of a number of CURE Epilepsy webinars this year that will discuss epilepsy in older adults. In subsequent webinars, we will learn about the association of epilepsy with conditions that often affect older adults such as neurodegenerative disorders. Please see www.CUREepilepsy.org/webinars for more information on all of our webinars.
Speaker
Dr. Mishra is the convener of the International Post Stroke Epilepsy Research Consortium (IPSERC), which he founded with Dr. Patrick Kwan, a Professor of Epileptology at Monash University, in 2021. He has been an active stroke researcher for the last two decades and currently focuses on understanding the mechanisms of post-stroke epilepsy. Advances in acute stroke management have led to improved survival after stroke, and therefore, more people are expected to have post-stroke epilepsy. It has become critical to speak to stroke patients to create awareness about the complications of stroke and understand their needs, e.g., how this condition affects their care and their quality of life. For example, these patients struggle to get back to driving because of physical deficits, including challenges from neglect and apraxia and the risk of unexpected future complications like seizures. Some stroke patients suffer from early seizures, e.g., acute symptomatic seizures and status epilepticus, and are, therefore, on antiseizure medications. Despite antiseizure medicines, many patients suffer from seizure recurrence. Dr Mishra will share his independent viewpoints about this medical problem in this webinar.
He is currently employed as the Stroke Director at the West Haven VA Medical Center and a stroke neurologist at the Yale New Haven Hospital. As a full-time faculty at Yale University, he conducts clinical research to improve the care of stroke patients.
ABOUT CURE EPILEPSY
CURE Epilepsy is the leading, non-governmental funder of epilepsy research. Since its inception in 1998, CURE Epilepsy has raised more than $90 million to fund epilepsy research and other initiatives that will lead the way to cures for the epilepsies. CURE Epilepsy funds grants for young and established investigators and to-date has awarded more than 285 cutting-edge projects in 18 countries around the world. Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research.
LEARN MORE ABOUT EPILEPSY
Visit the “Understanding Epilepsy” section of CURE Epilepsy’s website:
www.cureepilep...
STAY CONNECTED WITH CURE EPILEPSY
Sign up for our newsletter for the latest in epilepsy research news: www.cureepilep...
Follow us on Facebook: / cureforepilepsy
Follow us on Twitter: / cureepilepsy
Follow us on Instagram: / cureepilepsy
INCREASE YOUR IMPACT
Share your story: www.cureepilep...
Help us find a cure: www.cureepilep...
26 авг 2024
